Designed to provide a shock automatically when a heart arrhythmia is detected, the Defibtech Lifeline Auto fully automatic external defibrillator has been cleared for sale in the US market by the FDA.
The Lifeline Auto automatic external defibrillator’s advanced arrhythmia detection technology reduces the apprehension of concerned people who want to help, but may be hesitant to provide assistance, said Defibtech CEO Glenn W Laub. “The Lifeline Auto defibrillator does not require the rescuer to push a shock button. It shocks automatically when it identifies a shockable rhythm,” Laub said. “It is designed to give virtually anyone the ability to save a life with an automatic external defibrillator. It is very simple and unintimidating to use.”
One of the Lifeline family of automatic external defibrillators, the Lifeline Auto defibrillator also coaches responders through a rescue by providing step-by step audio prompts that describe how to apply the defibrillating pads to the victim and when to begin CPR. The Lifeline Auto defibrillator includes all mission critical features necessary to provide the most advanced treatment for sudden cardiac arrest.
The Lifeline Auto automatic external defibrillator was developed by experienced multidisciplinary engineering teams and incorporates state-of-the-art digital signal processing techniques and advanced ECG analysis algorithms. The device exceeds American Heart Association performance recommendations-giving the user confidence the correct therapy is being delivered. The Lifeline Auto defibrillator uses advanced biphasic technology-including the most studied biphasic shock waveform-and automatically adjusts the shock delivery to the person’s individual needs.